Antimicrobial susceptibility patterns of enterococci causing infections in Europe

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 10, 1999, Pages 2542-2546

  Schouten, M A ^a   Voss, A ^a   Hoogkamp Korstanje, J A A ^a   Jebelean, C ^b   Mittermayer, H ^b   Rotter, M ^b   Struelens, M J ^b   Keuleyan, E E ^b   Boras, A ^b   Schindler, J ^b   Bremmelgaard, A ^b   Renneberg, J ^b   Frimodt Moeller, N ^b   Lester, A ^b   Liimatainen, O O ^b   Vuopio Varkila, J ^b   Andremont, A ^b   Muller Serleys, C ^b   Etienne, J ^b   Raymond, J ^b   Bader, L ^b   Heesemann, J ^b   Luetticken, R ^b   Reinert, R R ^b   Peters, G ^b   Gross, R ^b   Shah, P M ^b   Syrogiannopoulos, G ^b   Vavatsi Manou, O ^b   Marton, A ^b   Nagy, E ^b   Block, C ^b   Yagupsky, P ^b   Botta, G A ^b   Marchiaro, G ^b   Stefani, S ^b   Gardovska, D ^b   Drukalska, L ^b   Usonis, V ^b   Endtz, H P ^b   Koeleman, J G M ^b   Meis, J F G M ^b   Sundsfjord, A ^b   Basta, M ^b   Heczko, P B ^b   Torbicka, E ^b   Melo Cristino, J ^b   Popova, I A ^b   Krcmercy Jr , V ^b   Gubina, M ^b   Asensi Botet, F ^b   Riestra, C ^b   Cervilla, J R ^b   Trilla, A ^b   Villa, J ^b   Burman, L G ^b   Laurel, M H ^b   Rylander, M ^b   Frei, R ^b   Kanra, G ^b   Chadwick, P R ^b   Price, E H ^b   Holzel, H ^b   more..

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFPIROME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; EVERNINOMICIN; GENTAMICIN; GLYCOPEPTIDE; IMIPENEM; MEROPENEM; MOXIFLOXACIN; ORITAVANCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TEICOPLANIN; TROVAFLOXACIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; ENTEROCOCCUS; ENTEROCOCCUS AVIUM; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0032871309     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.10.2542     Document Type: Article

References (18)

1. Baltch, A. L., R. P. Smith, W. J. Ritz, and L. H. Bopp. 1998. Comparison of inhibitory and bactericidal activities and postantibiotic effects of LY 333328 and ampicillin used singly and in combination against vancomycin-resistant Enterococcus faecium. Antimicrob. Agents Chemother. 42:2564-2568.
2. Bongaerts, G. P. A., and J. A. A. Hoogkamp-Korstanje. 1993. In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin and fleroxacin against gram-positive and gram-negative pathogens from respiratory tract and soft tissue infections. Antimicrob. Agents Chemother. 37:2017-2019.
3. Chow, J. W., S. M. Donabedian, and M. J. Zervos. 1997. Emergence of increased resistance of quinupristin/dalfopristin during therapy for Enterococcus faecium bacteremia. Clin. Infect. Dis. 24:90-91.
4. DeVriese, L. A., B. Pot, K. Kersters, S. Lauwers, and F. Haesebrouck. 1996. Acidification of methyl-α-D-glucopyranoside: a useful test to differentiate Enterococcus casseliflavus and Enterococcus gallinarum from Enterococcus faecium species group and Enterococcus faecalis. J. Clin. Microbiol. 34:2607-2608.
5. Dutka-Malen, S. S. Evers, and P. Courvalin. 1995. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J. Clin. Microbiol. 33:24-27.
6. Eliopoulos, G. M., C. B. Wennersten, H. S. Gold, T. Schulin, M. Souli, M. G. Farris, S. Cerwinka, H. L. Nadler, M. Dowzicky, G. H. Talbot, and R. C. Moellering, Jr. 1998. Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin. Antimicrob. Agents Chemother. 42:1088-1091.
7. Facklam, R. R., and M. D. Collins. 1989. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J. Clin. Microbiol. 27:731-734.
8. Fraise, A. P., J. Andrews, and R. Wise. 1997. Activity of a new glycopeptide antibiotic (LY 333328) against enterococci and other resistant gram-positive organisms. J. Antimicrobiol Chemother. 40:423-425.
9. Jones, R. N., H. S. Sader, M. E. Erwin, S. C. Anderson, and The Enterococcus Study Group. 1995. Emerging multiply resistant enterococci among clinical isolates. Prevalence data from a 97 medical centre surveillance study in the United States. Diagn. Microbiol. Infect. Dis. 21:85-93.
10. Lautenbach, E., M. G. Schuster, W. B. Bilker, and P. Brennan. 1998. The role of chloramphenicol in the treatment of bloodstream infections due to vancomycin-resistant Enterococcus. Clin. Infect. Dis. 27:1259-1265.
11. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A4. National Committee for Laboratory Standards, Villanova, Pa.
12. Sader, H. S., M. A. Pfaller, and F. C. Tenover. 1994. Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers. J. Clin. Microbiol. 32:2840-2842.
13. Schouten, M. A., and J. A. A. Hoogkamp-Korstanje. 1997. Comparative in-vitro activities of quinupristin/dalfopristin against gram-positive blood-stream isolates. J. Antimicrob. Chemother. 39:1-6.
14. Schouten, M. A., J. A. A. Hoogkamp-Korstenje, and A. Voss. 1997. Controlling glycopeptide-resistant enterococci. Clin. Microbiol. Infect. 3:592-593.
15. Schwalbe, R. S., A. C. McIntosh, S. Qaiyumi, J. A. Johnson, R. J. Johnson, K. M. Furness, W. J. Holloway, and L. Steele-Moore. 1996. In vitro activity of LY 333328, an investigational glycopeptide antibiotic against enterococci and staphylococci. Antimicrob. Agents Chemother. 40:2416-2419.
16. Struwig, M. C., P. L. Botha, and L. J. Chalkley. 1998. In vitro activities of 15 antimicrobial agents against clinical isolates of South African enterococci. Antimicrob. Agents Chemother. 42:2752-2755.
17. Urban, C., N. Moriano, K. Mosinka-Snipas, C. Wadee, T. Chahrour, and J. J. Rahal. 1996. Comparative in vitro activity of SCH 27899, a novel everninomicin, and vancomycin. J. Antimicrob. Chemother. 37:361-364.
18. Wade, J. J. 1995. The emergence of Enterococcus faecium resistant to glycopeptides and other standard agents. J. Hosp. Infect. 308:483-493.